Dislipidemia y riesgo aterogénico en pacientes con artritis reumatoide

Garrido, Jessica Roa; Olán, Francisco; Núñez, Éufrates Hernández

doi:10.1016/j.arteri.2016.02.002

Cited by 7 publications

(1 citation statement)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Currently much attention is focused on metabolic and immunologic markers which are likely to play one of the key roles in atherogenesis of autoimmune diseases. Recent studies provide convincing evidence that anti-cyclic citrullinated peptide antibodies (anti-CCP), rheumatoid factor IgM, circulating immune complexes, antiinflammatory cytokines (TNF-alfa, ІL-6), Th0/Th1 of Т-cells, homocysteine, dyslipidemia, decreased folic acid level, impaired vitamin metabolism as well as disturbances in paraoxonase activity can be involved in the development of cardiovascular diseases in RA (Yang et al, 2015;Batún Garrido et al, 2016;Rodríguez-Carrio et al, 2016;Tocci et al, 2016;Bernardes et al, 2017;Herly et al, 2017). Nowadays low paraoxonase activity is generally recognized as an independent risk factor of cardiovascular diseases involved in pathologic remodeling of the heart and vessels as well as thrombosis in the general population (Kerekes et al, 2008;Tang et al, 2012;Patra et al, 2013;Kovalenko et al, 2014;Wang et al, 2015;Kunutsor et al, 2016).…”

Section: Introductionmentioning

confidence: 99%

Serum paraoxonase activity in patients with rheumatoid arthritis, its relationship with the clinical course and cardiovascular compications

Шевчук¹,

Seheda²,

Galyutina³

et al. 2018

Regul. Mech. Biosyst.

View full text Add to dashboard Cite

Nowadays low paraoxonase activity is generally recognized as an independent risk factor of cardiovascular diseases involved in pathologic remodeling of the heart and vessels as well as thrombosis in the general population. But the role of paraoxonase activity in RA patients is unknown. Based on the above, the aim of the work was to study serum paraoxonase activity in patients with rheumatoid arthritis, to evaluate its association with clinical course and structural and functional status of the cardiovascular system. 67 patients with RA, 18 males and 49 females were studied. The control group consisted of 25 apparently healthy individuals. Rheumatoid arthritis was diagnosed according to international classification criteria ACR 2012. The indices of total cholesterol (TC), high density lipoprotein cholesterol (HDLC) and triglycerides (TG) in blood serum were determined by standard conventional methods. Low density lipoprotein cholesterol (LDLC) values were calculated by Friedwald formula. Serum paraoxonase activity was measured by spectrophotometric method. High resolution ultrasound and Doppler ultrasonography of the brachial artery were performed to study endothelium function. Sonographic B-mode scanning and pulsed Doppler ultrasound of heart and blood flow spectra were done on ultrasound scanner. Serum paraoxonase activity was found to be about 18.8% lower in the patients with RA than in the control group. Serum paraoxonase activity was shown to decrease proportionally to the increase of the age in RA patients. In the group of patients over 45, the level of the enzyme was 13.0% lower than in the patients over 30. The study established that the increase of systolic and diastolic arterial pressure is associated with decrease of serum paraoxonase activity in RA patients. The patients with RA combined with arterial hypertension had significantly (by 10.9%) lower activity of the studied enzyme than those with no arterial hypertension. However, no significant relationship between paraoxonase activity and duration of the disease, obesity and smoking was revealed. Paraoxonase activity in RA patients was demonstrated to be dependent on lipid levels. The lowest paraoxonase activity was recorded in individuals with the highest levels of TC, LDLC and the lowest HDLC indices. Paraoxonase activity in RA patients is associated not only with atherosclerotic vascular damage (IMT, decreased FMDBA) but also with structural and functional heart status (systolic and diastolic functions, left ventricular myocardial hypertrophy). Decreased serum paraoxonase level is suggested to be the predictor of early development of cardiovascular complications in RA patients.

show abstract

Section: Introductionmentioning

confidence: 99%

Serum paraoxonase activity in patients with rheumatoid arthritis, its relationship with the clinical course and cardiovascular compications

Шевчук¹,

Seheda²,

Galyutina³

et al. 2018

Regul. Mech. Biosyst.

View full text Add to dashboard Cite

show abstract

Metabolic syndrome in rheumatoid arthritis patients: Relationship among its clinical components

García‐Chagollán

Hernández-Martínez

Rojas-Romero

et al. 2020

Clinical Laboratory Analysis

View full text Add to dashboard Cite

show abstract

The Differential Influence of Immunological Process of Autoimmune Disease on Lipid Metabolism: A Study on RA and SLE

Chandrashekara¹,

Dhote²,

Anupama³

2017

Ind J Clin Biochem

View full text Add to dashboard Cite

Metabolic parameters like uric acid, lipids and homocysteine are influenced by immunopathological mechanisms underlying the autoimmune disease processes. The current study examined the differences in these parameters and the correlation between inflammatory and metabolic variables in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) patients. The cross-sectional prospective study included 24 treatment-naïve patients with moderate to severe diseases-15 subjects had RA and 9 had SLE. Atherogenic index of plasma (AIP) was used to assess the cardiovascular risk of the patients. Spearman's correlation was performed to verify the relationship between inflammatory and metabolic parameters. A two-tailed P \ 0.05 was considered statistically significant for all the analysis. SLE patients had higher uric acid levels, very low density lipoprotein-cholesterol, total cholesterol/high density lipoprotein-cholesterol ratio (TC/ HDL-C) and logarithmic ratio of triglycerides to HDL-cholesterol (log[TG/HDL-C]) than RA. Whereas, reduced total lymphocyte count, lipoprotein(a), and low density lipoprotein cholesterol were noted in the former than latter group. Majority of the SLE patients had increased risk of cardiovascular diseases ([ 0.24 AIP score) and RA patients in comparison had lower risk. Correlation among serum uric acid, lipid profile constituents and AIP was noted. The immunological process of SLE has greater impact on the metabolic parameters. Higher uric acid levels are suggestive of dysfunctional lipid profile. Understanding the implications of risk factors and its inflammatory role in autoimmune processes may assist in disease management.

show abstract

Dislipidemia y riesgo aterogénico en pacientes con artritis reumatoide

Cited by 7 publications

References 38 publications

Serum paraoxonase activity in patients with rheumatoid arthritis, its relationship with the clinical course and cardiovascular compications

Serum paraoxonase activity in patients with rheumatoid arthritis, its relationship with the clinical course and cardiovascular compications

Metabolic syndrome in rheumatoid arthritis patients: Relationship among its clinical components

The Differential Influence of Immunological Process of Autoimmune Disease on Lipid Metabolism: A Study on RA and SLE

Contact Info

Product

Resources

About